GLP-1 claims on TikTok: separating signal from noise

What did @suhaallaf actually say?

Honestly? It's not possible to tell. The transcript of this video is almost entirely incoherent, a fragmented stream of phrases that don't form medical claims, health advice, or any coherent narrative about GLP-1 medications. Fragments like "the oxygen weapon" and "the air probability to do is composition" are not decipherable health statements.

This appears to be either a heavily corrupted auto-transcription, content spoken in a language other than English that was machine-translated poorly, or audio that had significant background noise. Whatever the cause, there are no extractable medical claims about semaglutide, tirzepatide, liraglutide, or any other GLP-1 receptor agonist that can be evaluated in good faith.

The video has 592,800 views. That reach matters. And the fact that we can't tell what this person actually said is itself a problem worth naming.

Does the science back this up?

There is no coherent claim here to evaluate against the science. That's not a dodge, it's the honest answer. Fact-checking requires a claim, and this transcript does not contain one that can be responsibly extracted or attributed to the creator.

What we can say is that the GLP-1 category this video is tagged under is one of the most studied drug classes of the last decade. Semaglutide's cardiovascular benefit was demonstrated in the SUSTAIN-6 trial (Marso et al., 2016, New England Journal of Medicine). Tirzepatide's weight loss outcomes were reported in the SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine), showing up to 22.5% body weight reduction at 72 weeks. These are real, peer-reviewed findings. They deserve accurate representation, and this video, whatever it contains, does not appear to provide that.

What did they get wrong (or right)?

We cannot assign right or wrong to claims we cannot read. That said, the circumstantial concern here is significant. A video tagged under GLP-1 medications with nearly 600,000 views, producing a transcript that is entirely unintelligible, suggests one of several possibilities worth considering.

• The audio may be in Arabic, Somali, or another language, and the auto-transcription failed completely. If so, the actual content may be legitimate or may not be.
• The content may have no substantive medical information at all, meaning it's simply being algorithmically categorized under a trending health topic without earning that label.
• There is a small possibility the transcript represents a technical failure and real medical claims were made that we simply cannot access here.

None of these scenarios reflects well on the information environment around GLP-1 drugs on short-form video platforms. Viewers cannot benefit from health content they cannot understand, and platforms cannot be trusted to categorize it accurately.

What should you actually know?

GLP-1 receptor agonists are legitimate, FDA-approved medications with strong clinical evidence behind them, but they are also among the most misrepresented drugs on social media right now. A 2023 analysis published in JAMA Internal Medicine (Stehr et al.) found that a significant proportion of weight loss content on TikTok contains misleading or unverifiable claims.

If you're seeing a video tagged as GLP-1 content and can't understand what's being said, that's a signal to stop and look elsewhere. The decisions around starting, stopping, or adjusting a GLP-1 medication should be made with a licensed clinician who has access to your medical history, not through a social media video. Compounded versions of semaglutide and tirzepatide are not equivalent to FDA-approved branded formulations. Anyone telling you otherwise is cutting corners with your safety.

FormBlends connects patients with licensed providers who can evaluate whether GLP-1 therapy is appropriate for your individual situation. That conversation is worth having. This video, unfortunately, is not a useful input into it.